Low Prevalence of Thrombosis Prophylaxis Dose Adjustments Highlights Implications for Patient Safety
Background: Pharmacologic thromboprophylaxis (PTP) is the mainstay prevention strategy for venous thromboembolism (VTE). PTP agents traditionally dosed, like unfractionated heparin (UFH) and enoxaparin (ENOX), are associated with failure and bleeding in obese and underweight patients, respectively....
Guardado en:
Autores principales: | W. Anthony Hawkins, Susan E. Smith, Tia M. Stitt, Aliya Abdulla, Trisha N. Branan, Ronald G. Hall |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
University of Minnesota Libraries Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/26c378424349449b8b31e2593b8cd4d8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Current state of treatment for lower extremity acute deep venous thrombosis (a literature review)
por: A. O. Nykonenko, et al.
Publicado: (2021) -
Profilaxis de enfermedad tromboembólica en pacientes hospitalizados con patología médica, estrechando la brecha entre las guías y la práctica clínica
por: Aizman,Andrés, et al.
Publicado: (2011) -
Equivalent VTE rates after total joint arthroplasty using thromboprophylaxis with aspirin versus potent anticoagulants: retrospective analysis of 4562 cases across a diverse healthcare system
por: Chelsea Matzko, et al.
Publicado: (2021) -
Mean platelet volume as a prognostic factor for venous thromboembolic disease
por: Díaz,Juan Manuel, et al.
Publicado: (2019) -
Anticoagulation for Stroke Prevention after Restoration of Haemostasis with Emicizumab in Acquired Haemophilia A
por: Kadhim Al-Banaa, et al.
Publicado: (2021)